IMULDOSA
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for IMULDOSA, covering 2024-10-10 to 2026-03-30. Get the full timeline:
Most recent: EMA Authorised: Imuldosa (ustekinumab) — Accord Healthcare S.L.U.
4 regulatory and trial events tracked for IMULDOSA, covering 2024-10-10 to 2026-03-30. Get the full timeline:
Most recent: EMA Authorised: Imuldosa (ustekinumab) — Accord Healthcare S.L.U.